Palisade Bio (PALI) Restructuring Costs (2013 - 2026)
Palisade Bio (PALI) posted quarterly Restructuring Costs of $4.2 million for Q1 2026, up 213.14% year-over-year from $1.3 million in Q1 2025, and up 18.15% quarter-over-quarter from $3.6 million in Q4 2025.
Palisade Bio (PALI) Restructuring Costs (2013 - 2026) Analysis & Trends
Palisade Bio (PALI) has reported Restructuring Costs for 4 consecutive years, with $4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs rose 213.14% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $10.5 million (up 91.8% YoY), while the FY2025 annual figure was $7.6 million, up 38.37% from the prior year.
- Restructuring Costs improved to $4.2 million in Q1 2026 per PALI's latest filing, from $3.6 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $4.2 million in Q1 2026 and bottomed at $1.1 million in Q2 2025.
- Historically, Restructuring Costs has averaged $1.9 million across 3 years, with a median of $1.4 million in 2024.
- Annual changes were most pronounced in 2025 — Restructuring Costs fell 22.6% — and 2026, when it surged 213.14%.
- Palisade Bio's Restructuring Costs stood at $1.4 million in 2024, then soared by 158.13% to $3.6 million in 2025, then grew by 18.15% to $4.2 million in 2026.
- Business Quant data shows PALI's Restructuring Costs at $4.2 million in Q1 2026, $3.6 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.69 Mn |
| Mar 31, 2026 | 4.22 Mn |
| Dec 31, 2025 | 3.57 Mn |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Jun 30, 2013 | -131.00 |